IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -12.69% |
| Q3 2025 | 22.20% |
| Q2 2025 | -11.51% |
| Q1 2025 | 2.61% |
| Q4 2024 | -16.93% |
| Q3 2024 | -10.32% |
| Q2 2024 | -2.19% |
| Q1 2024 | -22.11% |
| Q4 2023 | -45.28% |
| Q3 2023 | 4.38% |
| Q2 2023 | -11.46% |
| Q1 2023 | -18.62% |
| Q4 2022 | -10.56% |
| Q3 2022 | -9.61% |
| Q2 2022 | -25.00% |
| Q1 2022 | -1.38% |
| Q4 2021 | -7.74% |
| Q3 2021 | -5.53% |
| Q2 2021 | -16.59% |
| Q1 2021 | 52.77% |
| Q4 2020 | -9.14% |
| Q3 2020 | -7.52% |
| Q2 2020 | -8.31% |
| Q1 2020 | -10.36% |
| Q4 2019 | -4.71% |
| Q3 2019 | -3.74% |
| Q2 2019 | -3.53% |
| Q1 2019 | -8.44% |
| Q4 2018 | 110.90% |
| Q3 2018 | 80.11% |
| Q2 2018 | -7.90% |
| Q1 2018 | 0.07% |
| Q4 2017 | 16.68% |
| Q3 2017 | -3.48% |
| Q2 2017 | -17.08% |
| Q1 2017 | 3.44% |
| Q4 2016 | -56.20% |
| Q3 2016 | -11.49% |
| Q2 2016 | -14.27% |
| Q1 2016 | -1.81% |